169 related articles for article (PubMed ID: 37906550)
1. Comparison of Magnetic Resonance Imaging and Endoscopic Ultrasound in the Sizing of Intraductal Papillary Mucinous Neoplasia of the Pancreas.
Hesse F; Ritter J; Hapfelmeier A; Braren R; Phillip V
Pancreas; 2023 Jul; 52(6):e315-e320. PubMed ID: 37906550
[TBL] [Abstract][Full Text] [Related]
2. Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas.
Huynh T; Ali K; Vyas S; Dezsi K; Strickland D; Basinski T; Chen DT; Jiang K; Centeno B; Malafa M; Klapman JB; Hodul PJ; Jeong D; Permuth JB
Pancreatology; 2020 Apr; 20(3):448-453. PubMed ID: 32113936
[TBL] [Abstract][Full Text] [Related]
3. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
[TBL] [Abstract][Full Text] [Related]
4. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
5. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
6. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
[TBL] [Abstract][Full Text] [Related]
7. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.
Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M
Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938
[TBL] [Abstract][Full Text] [Related]
8. Abdominal ultrasound in the characterization of branch-duct intraductal papillary mucinous neoplasms: A new tool for surveillance of low-risk patients?
Ferronato M; Lizzio CE; Berardinelli D; Marini D; Elia E; Andreetto L; Trentini A; Potenza MC; Serra C; Mazzotta E; Ricci C; Casadei R; Migliori M
Dig Liver Dis; 2024 Jun; 56(6):1071-1077. PubMed ID: 38042636
[TBL] [Abstract][Full Text] [Related]
9. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
[TBL] [Abstract][Full Text] [Related]
10. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
[TBL] [Abstract][Full Text] [Related]
11. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.
Pais SA; Attasaranya S; Leblanc JK; Sherman S; Schmidt CM; DeWitt J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):489-95. PubMed ID: 17350894
[TBL] [Abstract][Full Text] [Related]
12. MR Prediction of Malignant Switch With the Cyst Fluid's T2 Value in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Preliminary Study.
Takao S; Nishie A; Ushijima Y; Takayama Y; Morita K; Ishimatsu K; Koga Y; Mori Y; Akamine Y; Ishigami K
Anticancer Res; 2022 Aug; 42(8):3895-3903. PubMed ID: 35896240
[TBL] [Abstract][Full Text] [Related]
13. MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol.
Johansson K; Mustonen H; Nieminen H; Haglund C; Lehtimäki TE; Seppänen H
Abdom Radiol (NY); 2022 Feb; 47(2):727-737. PubMed ID: 34923598
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
15. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
[TBL] [Abstract][Full Text] [Related]
16. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
Smith LA; McKay CJ
Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
[TBL] [Abstract][Full Text] [Related]
17. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
[TBL] [Abstract][Full Text] [Related]
19. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
20. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
Siegel A; Friedman M; Feldman D; Krishnan K; Casey B; Pisuchpen N; Kambadakone A; Chung DC
Pancreatology; 2022 Nov; 22(7):951-958. PubMed ID: 35995658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
